drugset

drugset / Trial / NCT05819866

A Clinical Study to Assess the Efficacy and Safety of Leriglitazone in Adult Male Subjects With Cerebral Adrenoleukodystrophy

NCT05819866 ↗

Phase 3 Recruiting 40 enrolled Minoryx Therapeutics, S.L.

RandomizedParallel-groupTriple-blindTreatment

Summary

A Clinical Study to Assess the Efficacy and Safety of Leriglitazone in Adults Male Subjects with Cerebral Adrenoleukodystrophy.

Timeline

Start: 2023-07-12
Primary completion: 2027-05
Completion: 2027-05

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Leriglitazone	Small molecule	15 mg/ml	—

Indications